Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Energy

Cmb.Tech NV logoCmb.Tech NV

CMBT · the NYSE · USD · Market cap $5.1B

FAIL · Does not pass the screen
16.62 USD

Price as of 18 Nov 2026Daily close, not a live quote

Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price16.62 USD at the 18 Nov 2026 close
  • Our value readFair vs our fair value, as of 18 Nov 2026
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.39)
  • Last reviewed18 Nov 2026 (2 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $14.49 to $19.70, base estimate $17.13 (screen dated 2026-11-18).

Current read
Distribution ?
Fair · screened 2026-11-18
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.39, read 2026-11-19
  • Ethical does not pass the values gate
Price16.62 USD
Fair value17.13
Value readFairas of 18 Nov 2026
Our investment reviews on this name
2026-10-21Read Distribution17.35-4.2% to today ✓Accumulation gives way to Distribution with volume flow in agreement
2026-08-25Read Accumulation18.17-8.5% to today Markup gives way to Accumulation after a 23% rise in 8 weeks
2026-07-02Read Markup14.78+12.4% to today ✓First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Cmb.Tech NV holds its Distribution at $16.62. Consolidating, no directional conviction, held for 1 days.

As held on the ledger · 2026-11-18
PhaseDistribution · caution
Quantitative stateConsolidating, no directional conviction, held for 1 days
Price at the screen$16.62
Valuation5.92 trailing · 11.37 forward price to earnings
Values screenFAIL
Beta0.14
The Workings

Five Screens: CMBT's Results

FAIL. Debt ratio

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 128.02% Below 33% Fail
Interest-bearing cash 3.38% Below 33% Pass
Receivables 0.00% Below 49% Pass
Revenue purity 0.39% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Falls Short, in Plain English

Cmb.Tech's business is in a permissible area, but its interest-bearing debt is about 128% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when CMBT's ethical verdict changes

Today CMBT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Fair vs our fair value, as of 18 Nov 2026: it trades at roughly a 3% discount to our $17.13 fair value, weak competitive moat, 81.50% revenue growth.

Model construction and limits: fair-value methodology.

14.49Conservative17.13Base case19.70Growth case 16.62Price

Fair value range in USD, drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. A 3.0% discount to the base estimate.

The Street's Range
16.10Street low 21.25Street average 23.20Street high 16.62Price

Third-party analyst targets. The average target sits +28% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $17.13, with a range of $14.49 to $19.70, dated to the 2026-11-18 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words

Energy shipper looks cheap but carries heavy baggage

Picture a fleet of tankers chasing oil-price spikes one year and idling the next. CMB.Tech shows 121% revenue growth and a 25% profit margin, yet we pass. The forward multiple sits at just 10x and fair value offers only a slim buffer above the current price, but the business sits in a deeply cyclical trade where peak earnings often produce exactly this kind of low multiple.

The ethical screen fails on debt levels and the moat is rated weak, so even the 17% ROE does not compensate. Four analysts see a median target of $20, yet that optimism rests on the same commodity cycle that has crushed similar operators in past downturns.

High leverage leaves little room when rates or volumes turn, and the value-trap warning is clear: a low multiple on peak earnings is rarely a bargain. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E11.4xcheap for a company growing this fast
Trailing P/E5.9xvery cheap relative to earnings
EPS, trailing2.96
EPS, forward1.54
Revenue growth+81.5%growing very fast
Profit margin37.2%highly profitable on every dollar of sales
Return on equity29.6%an exceptional return on shareholder capital
FCF yield-15.91%
Dividend yield7.46%
Debt to equity1.75a meaningful debt load worth watching
Current ratio1.12adequate liquidity, worth monitoring
Beta0.14barely tracks the market's swings
Short interest, float0.03%
52-week range9.37 - 21.19
MoatWEAK
Market cap$5.1B

CMBT-specific watchpoints · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-18 Distribution $17.16 +3.1% Entry 12

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

2026-11-11 Distribution $16.65 -4.2% Entry 11

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

2026-11-04 Distribution $17.38 +0.2% Entry 10

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

2026-10-28 Distribution $17.35 +0.0% Entry 9

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

2026-10-21 Distribution · changed $17.35 -15.8% Entry 8

The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 15.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

2026-10-14 Accumulation $20.60 +8.7% Entry 7

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

2026-10-02 Accumulation $18.95 +4.3% Entry 6

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

2026-08-25 Accumulation · changed $18.17 +21.5% Entry 5

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 21.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

2026-07-25 Markup $14.96 +1.2% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

2026-07-18 Markup $14.78 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (4 analysts) rates it buy, with a mean price target of $19.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on CMBT

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in CMBT's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $17.35 -4.2% · $958 -4.2%
2 months $20.29 -18.1% · $819 -18.1%
3 months $17.62 -5.7% · $943 -5.7%
6 months $16.16 +2.8% $0.64 $1,068 +6.8%
1 year $9.39 +76.9% $0.80 $1,854 +85.4%
2 years $12.03 +38.2% $0.85 $1,452 +45.2%
3 years $12.01 +38.3% $7.14 $1,978 +97.8%
5 years $5.40 +207.8% $9.92 $4,915 +391.5%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CMBT does next, these words stay.

Cmb.Tech NV · CMBT · Distribution · $16.62
Recorded 2026-11-18 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.